| Date Filed | Type | Description |
| 08/18/2023 |
4
| Carruthers R Michael (CFO) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $7.08, valued at
$1.4M
|
|
| 05/03/2023 |
4
| Carruthers R Michael (CFO) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 1,336 shares
@ $8.9049, valued at
$11.9k
Exercised 5,208 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Carruthers R Michael (CFO) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 120,000 options to buy
@ $16.38, valued at
$2M
|
|
| 06/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/14/2016 |
4
| Carruthers R Michael (Exec Vice President / CFO) has filed a Form 4 on Nivalis Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $0 |
|